Page 89 - Looking Statement News Today

Share this article Share this article PHOENIX, Feb. 4, 2021 /PRNewswire/ -- Trutankless, Inc. (OTCQB: TKLS) manufactures an award-winning line of smart electric tankless water heaters. Trutankless has partnered with Cypress Industries based in Austin, Texas to launch production in North America. "We expect to see a tremendous improvement in our operating efficiencies along with increased manufacturing capabilities which we expect will yield benefits, especially as we prepare to launch additio...

Press release content from Business Wire. The AP news staff was not involved in its creation. Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert M. Davis as Successor; Frazier to Continue as Executive Chairman February 4, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Feb 4, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier w...

News Category Global Banking & Finance Reviews Ceridian to Acquire Ascender, a Leading Human Capital Management Provider Across 30 Countries in Asia Pacific Japan Ceridian to Acquire Ascender, a Leading Human Capital Management Provider Across 30 Countries in Asia Pacific Japan SYDNEY, Australia, Feb. 01, 2021 — Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM) technology, today announced it has entered into a definitive share sale agreement to acquir...

Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility TORONTO, Jan. 29, 2021 — Psyence Group Inc. (“Psyence” or the “Company”) is pleased to announce that it has concluded its first cultivation and harvest cycle of natural medical psilocybin mushrooms. The mushrooms were grown, harvested, processed, and packed at its premium production facility in Lesotho which has been designed and built to the highest international st...

Big Screen Bringing Sci-Fi Series ‘Singularity Principle’ to the Small Screen HOLLYWOOD, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — A fascinating science fiction series set around the mystery of parallel universes is being developed by Big Screen Entertainment Group (OTC: BSEG). “Singularity Principle” is adapted from the 2013 thriller movie of the same name, which was successfully distributed by BSEG. The movie is performing especially well on the company’s streaming service, Big Str...

Merck Announces Second Cohort of Safer Childbirth Cities Organizations Committed to Improving Maternal Health Equity and Reducing Preventable Maternal Deaths in the US Merck known as MSD outside the United States and Canada, announced today its funding support of a second cohort of nine city-based projects across the country — expanding its Safer Childbirth Cities initiative to additional communities that have a high burden of maternal mortality and morbidity to help improve maternal health o...

Theralase Technologies Inc.: Theralase Launches Fourth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study Theralase® Technologies Inc. (" TSXV:TLT) ( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that Carolina Urologic Research Center ("C URC")...

(2) KEYTRUDA Is First Checkpoint Inhibitor Approved in Europe to Treat MSI-H or dMMR Colorectal Cancer European Approval Based on Results From KEYNOTE-177 Trial Demonstrating KEYTRUDA Significantly Reduced Risk of Disease Progression or Death by 40% Compared With Chemotherapy Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the European Commission has approved KEYTRUDA, Mercks anti-PD-1 therapy, as a monotherapy for the first-line treatment of adult pa...

Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection at HIVR4P 2021 Clinical Trial is Part of the Company’s HIV-1 Prevention Clinical Program Studying Islatravir as a Long-Acting PrEP Agent The company’s investigational oral nucleoside reverse transcriptase translocation inhibitor for pre-exposure prophylaxis . Interim findings demonstrate that once-monthly oral islatravir achieved the pre-...

Press release content from Business Wire. The AP news staff was not involved in its creation. Merck Announces Second-Quarter 2021 Dividend January 26, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Jan 26, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.65 per share of the company’s common stock for the second quarter of 2021. Payment will be made on April 7, 2021 to shareholders of r...